After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...

Investors in Rubius Therapeutics, Inc. RUBY need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 16, 2021 $20.00 Put had some of the highest ...

Rubius Therapeutics (NASDAQ:RUBY) stock is heading higher on Tuesday despite a lack of news from the cellular medicines company. Instead, it looks like increasing interest from traders is behind today ...

Rubius Therapeutics intends to raise $200 million in a U.S. IPO. The pre-clinical stage firm aims to develop treatments using red blood cells as the delivery mechanism. RUBY's IPO valuation is quite ...

Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want? One thing's for sure: You'll never discover truly ...

Ruby Tuesday (RT) shares are declining after the restaurant chain reported a quarterly net loss that was wider than analysts were expecting. The Maryville, TN-based company reported a second quarter ...